Although peripheral blood engraftment was detected in both CD34+CD117+ and CD34+CD117− NSG recipient mice at week 12 post-engraftment, the frequency and absolute count of AML cells were significantly greater in CD34+CD117+ NSG recipient mice in a dose-dependent manner (Fig. 4b, c). This evidence concerns the gene KIT and acute myeloid leukemia.